COMMUNIQUÉS West-GlobeNewswire

Agomab Announces Appointments of Marino Garcia and Dr. Naimish Patel to Board of Directors
11/09/2026
Antwerp, Belgium, September 11, 2026 – Agomab Therapeutics NV (Nasdaq: AGMB) (“Agomab” or the “Company”), a clinical-stage biopharmaceutical company focused on fibro-inflammatory diseases, today announced that [...]
4DMT Announces New Employment Inducement Grants
11/09/2026
EMERYVILLE, Calif., Sept. 11, 2026 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with [...]
Impact BioMedical Inc (NYSE American: IBO) Announces 1 for 12.62 Reverse Stock Split to Pursue Completion of Merger with Zoar Ltd. (previously Dr. Ashley’s Ltd.)
11/09/2026
HOUSTON, Sept. 11, 2026 (GLOBE NEWSWIRE) -- Impact BioMedical Inc. (the “ Company ”) today announced that the Company's Board of Directors has approved a 1 for 12.62 reverse stock split of the Company's issued and [...]
Korro Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
11/09/2026
CAMBRIDGE, Mass., Sept. 11, 2026 (GLOBE NEWSWIRE) -- Korro Bio, Inc. (Korro) (Nasdaq: KRRO), a biopharmaceutical company leveraging a novel Oligonucleotide Promoted Editing of RNA (OPERA ® ) platform to develop a new [...]
Corbus Pharmaceuticals to Host Conference Call to Discuss Topline Data from CANYON-1 Clinical Trial and the Potential of CRB-913 In Obesity
11/09/2026
Virtual Webcast to be Held Monday, September 14, 2026, at 8:00 AM EDT NORWOOD, Mass., Sept. 11, 2026 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings, Inc. (Nasdaq: CRBP), a clinical-stage company focused on [...]
Erica Zarkovich, Chief Market and Partnerships Officer, Named One of Canada’s Most Powerful Women: Top 100
11/09/2026
Toronto, Canada, Sept. 11, 2026 (GLOBE NEWSWIRE) -- Erica Zar kovich, Chief Market and Partnerships Officer, has been named one of Canada’s Most Powerful Women: Top 100 by WXN Media in the CN Executive Leaders category [...]
MEDIA ADVISORY: New Report Tracking Under-Used Hospitals, Deficits, Cuts & Inequities in Health Care Across Ontario
11/09/2026
Attn: Assignment Editor/News Desk TORONTO, Sept. 11, 2026 (GLOBE NEWSWIRE) -- The Ford government has continued to expand its privatization of local public hospitals' services. A raft of new private clinics is planned [...]
Omniscient Secures Third FDA Clearance, Extending Its Connectomic Platform into the Fast-Growing Deep Brain Stimulation Market
11/09/2026
The clearance of Quicktome’s Deep Brain (DB) workflow marks Omniscient's third FDA milestone and its entry into DBS, advancing the company's strategy to provide actionable brain insights across neurosurgery and [...]
FDA approves Pharming’s Joenja® as first treatment for children with APDS in the U.S.
11/09/2026
FDA approval expands Joenja indication to include children with activated phosphoinositide 3-kinase delta (PI3Kδ) syndrome (APDS) ages 4 to 11 who weigh at least 27kg Newly approved Joenja doses are expected to be [...]
Gartner Names ABBYY a Leader in its 2026 Magic Quadrant for Intelligent Document Processing
11/09/2026
AUSTIN, Texas, Sept. 11, 2026 (GLOBE NEWSWIRE) -- ABBYY has been named a Leader in the 2026 Gartner Magic Quadrant for Intelligent Document Processing (IDP). It is ABBYY's second recognition in the Gartner second [...]
Sanofi: Information concerning the total number of voting rights and shares - August 2026
11/09/2026
Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the Règlement général de l’ [...]
Sanofi: Informations relatives au nombre de droits de vote et d'actions - AOUT 2026
11/09/2026
Informations relatives au nombre total de droits de vote et d’actions prévues par l’article L. 233-8 II du Code de commerce et l’article 223-16 du Règlement général de l’Autorité des Marchés Financiers Sanofi Société [...]
Orion Corporation: Acquisition of own shares during week 37, 2026
11/09/2026
Orion Corporation: Acquisition of own shares during week 37, 2026 The share buybacks form part of the share buyback programme that Orion Corporation announced on 27 August 2026. The buyback programme runs from 1 [...]
Vystar Enters the Digital Economy Through R3alm Ownership
11/09/2026
Vystar’s 50 percent interest places the public company inside r3alm’s developing 22-module AI, digital-finance and tokenized-asset ecosystem BOSTON, MA, Sept. 11, 2026 (GLOBE NEWSWIRE) -- R3alm and Vystar Corporation ( [...]
Dance Fitness Tempe Announces Expansion of Accessible Digital Movement Programs
11/09/2026
TEMPE, Arizona, Sept. 11, 2026 (GLOBE NEWSWIRE) -- Dance Fitness Tempe today announced the launch of expanded digital dance content and free online workout programs aimed at making movement accessible to its growing [...]
Dental Implant Surgery and Implant Restoration: What Patients Need to Know
11/09/2026
Implant position, depth and angulation are decided during surgery, and the restoration built afterward cannot undo them. Institute for Advanced Dentistry & Implants manages dental implant surgery and implant [...]
Quantum BioPharma Ltd. (NASDAQ: QNTM) Filling Key Gap in MS Treatment, Cleared by FDA to Launch Historic Trials
11/09/2026
NEW YORK, Sept. 11, 2026 (GLOBE NEWSWIRE) -- via BioMedWire — Quantum BioPharma Ltd. (NASDAQ: QNTM) today announces its placement in an editorial published by BioMedWire (BMW), one of 75+ brands within the Dynamic Brand [...]
Moleculin Presentation from H.C. Wainwright Conference Now Available On-Demand
11/09/2026
Access the video webcast here HOUSTON, Sept. 11, 2026 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc. , (Nasdaq: MBRX) (“Moleculin” or the “Company”), today announced that its pre-recorded presentation from the H.C. [...]
Allarity Therapeutics Announces Strategic Capital Allocation for Filing of SPAC Registration Statement
11/09/2026
TARPON SPRINGS, Fla., September 11, 2026 – Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a Phase 2 clinical-stage pharmaceutical company dedicated to developing stenoparib—a differentiated [...]

Pages